CTOs on the Move

Beyond Intractability

www.beyondintractability.org

 
Welcome to the Moving Beyond Intractability online discussion of hyper-polarization and intractable conflict . This is a new project built on top of the long standing Beyond Intractability Knowledge Base with the goal of moving beyond the limits of current knowledge, and helping as many people as possible "move beyond" intractability in the conflicts they are involved in and care deeply about. You can also follow this discussion on our Substack newsletter: https://beyondintractability.substack.com/ The goal of these discussions is to explore -- with as many people as possible the many intractable conflicts that seem to be tearing the ...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

3:AM DESIGN

3:AM DESIGN is a Toronto, ON-based company in the Business Services sector.

Pro Pharmaceuticals, Inc.

DAVANAT, the Company's lead product candidate, is a targeted therapeutic compound composed of a complex carbohydrate polymer. DAVANAT's mechanism of action is targeting lectins on the tumor cell surface.

bacinvestments

BAC Florida Investments Corp. offers a broad array of customized investment brokerage services and solutions to Latin American and U.S. clientele. We provide strategic solutions to effectively grow our clients’ financial assets.

Caring

IR-Med Inc. (OTCQB:IRME)

IR-MED Inc. is developing a cutting-edge infrared spectroscopy and AI analysis technology platform as a basis for point-of-care decision support devices. The infrared spectroscopy technology allows harmless and non-invasive gathering of bio-information from patient blood and tissue. Bioinformation is then analyzed using the companys AI process to provide healthcare professionals with decision support in the detection and monitoring of various disease conditions. PressureSafe, the companys first product based on this platform, is a handheld device designed to revolutionize early detection of pressure injuries (PI) affecting skin and underlying tissue. Pressure Injury in the US alone accounts for $26.8B in healthcare spending and results in 60,000 deaths annually. PressureSafe is expected to contributes to early detection of pressure injuries, regardless of patient skin tone. This will drive equitable healthcare and help reduce the toll and cost of PI. IR-MED holds patents protecting its innovation in noninvasive tissue analysis, and in modeling and analysis of subcutaneous tissue.